Bullish & Foolish
Full XCUR fundamentals All 466 on the Survival Watch

XCUREXICURE, INC.

Is Exicure struggling financially?

Yes, by its own account. Exicure told the SEC on 29 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

15/100

Critical

Sector
Biotech/Pharma
Market cap
$7.5M
Source filing
10-Q 29 May 2026
Balance sheet
30 Jun 2026

Cash runway

  • 2months

    If the burn speeds up

    Empty by Aug 2026

  • 3months

    If it eases off

    Empty by Sep 2026

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$1.7M

÷

Cash burned over the last 12 months

$8.6M

What Exicure told the SEC

…capital that is needed to fund our operations and our pursuit of strategic alternatives, particularly given our current lack of a revenue source and the substantial doubt about our ability to continue as a going concern; our ability to remain listed on The Nasdaq Capital Market (“Nasdaq”), including the ability to comply with the minimum stockholders’ equity requirement and maintain stock price, and…

EXICURE, INC., Form 10-Q, filed 29 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

Other Biotech/Pharma companies that filed the doubt